PMC:7195088 / 31841-32042
Annnotations
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T26 | 185-190 | Body_part | denotes | scale | http://purl.obolibrary.org/obo/UBERON_0002542 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T164 | 68-76 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T178 | 167-170 | http://purl.obolibrary.org/obo/CLO_0001608 | denotes | a 7 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T430 | 14-25 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T252 | 78-129 | Sentence | denotes | Double-blind RCT (NCT04320615, not yet recruiting). |
T253 | 130-201 | Sentence | denotes | Primary endpoint: severity rating on a 7-point ordinal scale at day 28. |